Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Emily D. Parker, PhD, MPH
Advertisement
Articles by Emily D. Parker, PhD, MPH
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Physician practices account for a significant amount of variation in spending.
Advertisement
Latest Updated Articles
- Variation in Spending Associated With Primary Care Practices
December 15th 2020
Advertisement
Advertisement
Trending on AJMC
1
FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies
2
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
3
A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD
4
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
5